Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Select your species
Pig (Porcine) FGF19 ELISA Kit für Sandwich ELISA - ABIN857062
Vlaardingerbroek, Ng, Stoll, Benight, Chacko, Kluijtmans, Kulik, Squires, Olutoye, Schady, Finegold, van Goudoever, Burrin: New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. in Journal of lipid research 2014
Rat (Rattus) FGF19 ELISA Kit für Sandwich ELISA - ABIN433249
Fotschki, Juśkiewicz, Jurgoński, Rigby, Sójka, Kołodziejczyk, Mackie, Zduńczyk: Raspberry pomace alters cecal microbial activity and reduces secondary bile acids in rats fed a high-fat diet. in The Journal of nutritional biochemistry 2017
These data identify hypothalamic Fgf15 as a regulator of glucagon (zeige GCG ELISA Kits) secretion.
Fgf15 is the sonic hedgehog (zeige SHH ELISA Kits) downstream signal to control thalamic regionalization, neurogenesis, and neuronal differentiation by regulating the expression and mutual segregation of neurogenic and proneural regulatory genes.
human microbiota was able to reduce the levels of tauro-beta-muricholic acid and induce expression of FXR (zeige NR1H4 ELISA Kits) target genes Fgf15 and Shp (zeige LAMC1 ELISA Kits) in ileum after long-term colonization. We show that a human microbiota can change BA composition and induce FXR (zeige NR1H4 ELISA Kits) signaling in colonized mice, but the levels of secondary BAs produced are lower than in mice colonized with a mouse microbiota
This study demonstrates that the FGF19-SHP (zeige LAMC1 ELISA Kits)-LSD1 (zeige KDM1A ELISA Kits) axis maintains homeostasis by suppressing unnecessary autophagic breakdown of cellular components, including lipids, under nutrient-rich postprandial conditions.
The elevation in circulating levels of adiponectin and Fgf15 led to normalized hepatic and serum levels of bile acids, limited hepatic accumulation of toxic bile, attenuated inflammation, and amelioration of liver injury in the ethanol-fed mNT knockout mice.
This study reveals SHP (zeige LAMC1 ELISA Kits) as a global transcriptional partner of SREBP-2 (zeige SREBF2 ELISA Kits) in regulation of sterol biosynthetic gene networks and provides a potential mechanism for cholesterol-lowering action of FGF19.
Protective effects of farnesoid X receptor on hepatic lipid accumulation are mediated by hepatic FXR (zeige NR1H4 ELISA Kits) and are independent of intestinal FGF15 signaling.
In mice with humanized livers human hepatocytes do not recognize FGF-15 produced by mouse intestine, resulting in up-regulation of bile acid synthesis enlargement of the bile acid pool, affecting the hepatostat.
Intestinal PPARalpha (zeige PPARA ELISA Kits)-UDP- Glucuronyltransferases and downstream FXR (zeige NR1H4 ELISA Kits)-FGF15 signalling play vital roles in control of bile acid homeostasis and the pathological development of colitis.
a direct role of intestinal FGF15/19 in the regulation of SI P450 (zeige POR ELISA Kits) expression and may have profound implications for the prediction of drug exposure in patients with compromised hepatic P450 (zeige POR ELISA Kits) function
This is the first study to elucidate FGF19/FGFR4 (zeige FGFR4 ELISA Kits) signaling in favor of hepatocellular carcinoma cells developing from fatty liver
High expression of FGF19 is associated with hepatocellular carcinoma.
Findings show that FGF19 provides a cytoprotective role against ER stress by activating a FGFR4 (zeige FGFR4 ELISA Kits)-GSK3beta (zeige GSK3b ELISA Kits)-Nrf2 (zeige GABPA ELISA Kits) signaling cascade, suggesting targeting this signaling node as a candidate therapeutic regimen for hepatocellular carcinoma (HCC (zeige FAM126A ELISA Kits)) management.
Fibroblast growth factor 19 levels in human portal blood are higher than in arterial blood. Fibroblast growth factor 19 is released by the portal-drained viscera under fasted steady state conditions.
serum FGF19 and FGF21 (zeige FGF21 ELISA Kits) and hepatic Klotho (zeige KL ELISA Kits) expression are inversely associated with hepatic damage in children with NAFLD (zeige TSC2 ELISA Kits)
Administering FGF19, or suitable mimetic, as a pharmacological intervention to increase circulating levels of FGF19 and suppress BA synthesis by inhibiting CYP7A1 (zeige CYP7A1 ELISA Kits) gene expression is likely to provide therapeutic benefits for many PBC (zeige DLAT ELISA Kits) patients
Amplification of FGF19 was validated in independent LSCC samples. Furthermore, FGF19 stimulated LSCC cell growth in vitro. These data implicate FGF19 as a potential driver gene in LSCC with clinic characteristics as smoking.
FGF19 is able to enhance migration and invasion abilities of gastric cancer cells.
Bile acid and FGF19 levels increased after Roux-en-Y bypass, but not after intensive medial management in type 2 diabetic subjects who achieved similar improvement in glycemic control.
FGF19 correlates with severity of liver disease and can potentially serve as an indicator of chronic cholestatic liver injury.
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes including embryonic development cell growth, morphogenesis, tissue repair, tumor growth and invasion. This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development.
fibroblast growth factor 19
, fibroblast growth factor 15